Marksans Pharma

Discussion in 'Ask A Query About Your Stock Picks And Portfolio' started by jeett, May 3, 2015.

Previous Thread Next Thread
Loading...
  1. jeett

    jeett Member

    Joined:
    May 2, 2015
    Messages:
    62
    Likes Received:
    14
    Hello,

    What are long term prospects of Marksans Pharma? Can one hold onto this stock for long?

    Bhavesh
     
    jeett, May 3, 2015
    #1
  2. ayan.ghosh

    ayan.ghosh New Member

    Joined:
    Mar 21, 2015
    Messages:
    13
    Likes Received:
    0
    there is a idfc report on marksman ... what is your entry level?
     
    ayan.ghosh, May 3, 2015
    #2
  3. jeett

    jeett Member

    Joined:
    May 2, 2015
    Messages:
    62
    Likes Received:
    14
    I have 1600 @ 55.

    Can you please share the IDFC report with me?

    Thanks
    Bhavesh
     
    jeett, May 3, 2015
    #3
  4. Parin Gala

    Parin Gala A long term investor

    Joined:
    Mar 19, 2015
    Messages:
    252
    Likes Received:
    157
    I have been tracking the stock since the price was in single digit. The company's top line and bottom line have improved substantially.

    Since the last some quarters FIIs are also interested in the counter. Also, it is not as expensive as some of the other midcap pharma companies.
     
    Parin Gala, May 3, 2015
    #4
  5. ayan.ghosh

    ayan.ghosh New Member

    Joined:
    Mar 21, 2015
    Messages:
    13
    Likes Received:
    0
    Link for Karvy report https://www.moneycontrol.com/news/brokerage-recosfundamental/buy-marksans-pharma-targetrs-73-karvy_1282236.html

    would share the link for idfc report in some time 8)
     
    ayan.ghosh, May 3, 2015
    #5
  6. Meenakshi Razdan

    Meenakshi Razdan Administrator Staff Member Moderator

    Joined:
    Mar 19, 2015
    Messages:
    430
    Likes Received:
    150
    Marksans is a highly regarded stock by some knowledgeable investors. Ravi Dharamshi Of ValueQuest said this about Marksans in a recent interview:

    "Marksans Pharma – multi-bagger gains possible:

    Marksans Pharma has a promoter who is hungry to perform. It had problems with BIFR and is coming out of a very problematic place. It is in a sweet spot where it is addressing the OTC generic market in the US. That is a space which is not very competitive. It is a small space, but it is large enough for them to be able to grow to a Rs 2000-3000 crore kind of a size from the current Rs 500-600 crore.    "

    IIFL has recommended a buy on the basis that:


    Robust play on niche US softgel opportunity
    European business on sustainable footing
    Expect stellar ~37% EPS cagr over FY15-17E

    https://content.indiainfoline.com/wc/research/researchreports/Marksans_Pharma_150315.pdf
     
    Meenakshi Razdan, May 3, 2015
    #6
Previous Thread Next Thread
Loading...
Loading...
Similar Threads
  1. Vidhi Khanna

    Piramal Pharma's long term prospects are intact. Buy for target price of ₹290 (+38%)

    Vidhi Khanna, May 15, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    404
    Vidhi Khanna
    May 15, 2025
  2. Vidhi Khanna

    Pharmaceuticals Sector Update

    Vidhi Khanna, May 13, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    353
    Vidhi Khanna
    May 13, 2025
  3. Vidhi Khanna

    Review of 16 Pharma stocks with Buy, Hold & Sell recommendations.

    Vidhi Khanna, Apr 21, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    336
    Vidhi Khanna
    Apr 21, 2025
  4. Vidhi Khanna

    Buy Sun Pharma for TP of ₹2400 (+45.3%)

    Vidhi Khanna, Apr 14, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    358
    Vidhi Khanna
    Apr 14, 2025
  5. Vidhi Khanna

    Citi Sees Low Risk Of US Tariffs On Indian Pharma; Prefers Torrent Pharma, Divi's

    Vidhi Khanna, Apr 1, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    426
    Vidhi Khanna
    Apr 1, 2025